COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03053466
Recruitment Status : Recruiting
First Posted : February 15, 2017
Last Update Posted : September 10, 2020
Novotech (Australia) Pty Limited
Apollomics Inc. (formerly CBT Pharmaceuticals, Inc.)
Information provided by (Responsible Party):
Apollomics (Australia) Pty. Ltd.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : December 2021